Kristen Lowery, PA
Physician Assistant · Asheville, NCNPI 1316362817
Payments from drug & device makers
Across 67 payments — averaging $21.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$317
- Johnson & Johnson$130
- Pfizer$110
- Incyte Corporation$80
- Eisai Inc.$69
- AbbVie$68
- plus $695 from 23 others
What the payments were for
- Food & beverage$1,40496%
- Education$654%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 14 | $317 |
| Johnson & Johnson | 7 | $130 |
| Pfizer | 6 | $110 |
| Incyte Corporation | 2 | $80 |
| Eisai Inc. | 3 | $69 |
| AbbVie | 3 | $68 |
| Regeneron Healthcare Solutions, Inc. | 1 | $64 |
| AstraZeneca | 3 | $61 |
| Lilly USA, LLC | 3 | $55 |
| Deciphera Pharmaceuticals Inc. | 2 | $54 |
| Daiichi Sankyo Inc. | 2 | $52 |
| Gilead | 2 | $40 |
| Array Biopharma Inc | 2 | $37 |
| Beigene USA, Inc. | 2 | $29 |
| Sanofi | 1 | $27 |
| Bristol Myers Squibb | 1 | $26 |
| Boehringer Ingelheim | 1 | $25 |
| Astellas Pharma US Inc | 1 | $24 |
| G1 Therapeutics, Inc. | 1 | $23 |
| Janssen Scientific Affairs, LLC | 1 | $23 |
| Servier Pharmaceuticals LLC | 1 | $22 |
| Merck | 1 | $21 |
| Bayer | 1 | $21 |
| Kyowa Kirin, Inc. | 1 | $19 |
| AVEO Pharmaceuticals, Inc. | 1 | $16 |
| Amgen | 1 | $15 |
| Tersera Therapeutics LLC | 1 | $15 |
| E.r. Squibb & Sons, L.L.C. | 1 | $14 |
| Epizyme, Inc. | 1 | $14 |
How this compares
$1,469 in reported general payments places this provider in the 75th percentile of 7,441 physician assistant providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone Hcl | 27 | $568 |
| Hydroxyurea | 13 | $517 |
| Dexamethasone | 25 | $462 |
| Ondansetron OdtOndansetron | 19 | $409 |
| Acyclovir | 14 | $314 |
| Anastrozole | 12 | $164 |
| Prochlorperazine Maleate | 16 | $153 |
| Pregabalin | 13 | $136 |
| Levothyroxine Sodium | 11 | $56 |
Paid to pharmacies, not to this prescriber.
Other physician assistant in Asheville
- Jeremy DavidsonAsheville$96K
- John AveretteAsheville$34K
- Carrie VoedischAsheville$32K
- Jo HughesGreensboro$814K
- Rachel HolzhauerCharlotte$739K
- Amber BlairCharlotte$551K
- Benjamin EpsteinDavidson$447K
- Rebecca KrausDavidson$425K
- Brooke JonesGoldsboro$259K
- Philip ReasbeckWilson$180K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.